The results were studied among children and adults with mpox in the Democratic Republic of the Congo, according to an Aug. 15 news release from the National Institutes of Health. Detailed results will be released through scientific channels, the NIH said.
National Institute of Allergy and Infectious Diseases Director Jeanne Marrazoo, MD, called the results “disappointing” and said they “reinforce the need to identify other therapeutic candidates for mpox.”
The World Health Organization on Aug. 14 declared the mpox outbreak in the Democratic Republic of the Congo and other African countries a public health emergency of international concern.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
